A federal judge in Texas ruled that three states can challenge the current rules of accessibility for abortion pills.

Trump-appointed Judge Matthew Kacsmaryk ruled Thursday that Idaho, Kansas, and Missouri can pursue legal action to prohibit the FDA from allowing online prescriptions.

Instead of dismissing the case, Judge Matthew Kacsmaryk said three states with no connection to Texas can sue the FDA to try to reimpose restrictions on mifepristone.

a federal judge in Texas ruled on Thursday. U.S. District Judge Matthew Kacsmaryk in Amarillo decided that the three states can continue their case against the U.S. Food and Drug Administration in his court, where they last year joined a lawsuit originally ...

Rather than target the approval entirely, they sought to undo a series of FDA updates that have eased ... the request in U.S. District Court in Amarillo, Texas. The only judge based there is ...

Rather than target the approval entirely, they sought to undo a series of FDA updates that have eased access ... Kansas and Missouri made the request in U.S. District Court in Amarillo, Texas. The only judge based there is Matthew Kacsmaryk, a nominee ...

Idaho, Kansas and Missouri requested late last year to pursue the case in federal court in Amarillo, Texas, after the U.S. Supreme Court ... so his administration will likely be representing the FDA in the case. Trump has repeatedly said abortion is ...

The states of Idaho, Kansas and Missouri made the request in U.S. District Court in Amarillo, Texas. The only judge ... will likely be representing the FDA in the case. Trump has repeatedly ...

Lubbock had at least 17 business changes, from Llano Estacado being sold to Dave's Hot Chicken opening and Pei Wei closing. Here's what happened.

A new study shows a possible new abortion drug to replace mifepristone. But will these results increase abortion access—or restrict women's reproductive health options down the line?

Gameto, a clinical-stage biotech company developing iPSC-based therapies for women’s health, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for Fertilo,

Amarillo College’s Board of Regents has approved the contract for their incoming president during Tuesday’s meeting.